Latest Strategy News

Eagle Mountain Mining has successfully renegotiated its US$7.25 million loan with Vincere, gaining a 12-month repayment extension and a discounted early repayment option tied to key project agreements.

Eagle Mountain Mining has secured a 12-month exclusive option to acquire the Oracle Ridge copper mine’s surface and mineral rights, positioning the company to potentially restart production on a resource containing 380,000 tons of copper.

Alice Queen Limited is updating its Horn Island Gold Project scoping study following a dramatic gold price increase, while engaging GBA Capital to explore financing options.

FBR Limited has inked a non-binding Memorandum of Understanding with Fraser Lyne Constructions for the sale of a Hadrian® bricklaying robot unit valued at A$7.8 million, aiming to tackle New South Wales' housing shortage with advanced automation.

ARC Funds Limited has strategically acquired $2.15 million face value of convertible notes in ausbiz TV at just 20% of their value, issuing 4.47 million new shares as consideration. This move aligns with ARC’s growth strategy to diversify income streams and deepen its investment platform.

BPH Global has locked in a six-month exclusive agreement to evaluate a proprietary ginseng-based formulation aimed at enhancing male vitality, signaling a strategic push into Traditional Chinese Medicine-inspired wellness products.

Peel Mining Limited reveals a robust high-grade resource base and ongoing exploration in the Cobar Basin, positioning itself for growth amid a dynamic regional mining landscape.

ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.

Austral Resources Australia Ltd has successfully completed a $40 million capital raise and is reinstated to ASX trading, positioning itself as a mid-tier copper producer with a dual-hub operation in Queensland.

Energy Transition Minerals has appointed two former Danish diplomats to its Advisory Board, aiming to strengthen its rare earths project in Greenland amid ongoing legal challenges.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.

Nanosonics Limited has announced a $20 million on-market share buy-back program for FY26, underscoring its robust financial health and confidence in future growth driven by new product innovations.